Cellosaurus WIL2 MTIr-107 (CVCL_A6HR)
Cell line name | WIL2 MTIr-107 | |
---|---|---|
Synonyms | MTIr-107; MTIr mutant 107 | |
Accession | CVCL_A6HR | |
Resource Identification Initiative | To cite this cell line use: WIL2 MTIr-107 (RRID:CVCL_A6HR) | |
Comments | Population: Caucasian. Selected for resistance to: ChEBI; CHEBI:44081; 6-methylthioinosine (6-methylmercaptopurine riboside). Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Derived from site: In situ; Spleen; UBERON=UBERON_0002106. | |
Sequence variations |
| |
Disease | Hereditary spherocytosis (NCIt: C97074) Hereditary spherocytosis (ORDO: Orphanet_822) | |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | |
Hierarchy | Parent: CVCL_6544 (WIL2) Children:
| |
Sex of cell | Male | |
Age at sampling | 5Y | |
Category | Transformed cell line | |
Publications | PubMed=197600; DOI=10.1126/science.197600 | |
Cross-references | ||
Encyclopedic resources | Wikidata; Q107117459 | |
Entry history | ||
Entry creation | 20-May-2021 | |
Last entry update | 29-Jun-2023 | |
Version number | 4 |